Skip to main content

Indian Govt has banned about 300 drugs

Drugs from a number of prominant companies has been banned by the Indian Government. This is done in lieu of an alarming number of people developing high resistance to anti biotics.

Please do check your drugs before taking them.

Source - Hindutan Times

URL - http://www.hindustantimes.com/india/not-just-vicks-and-benadryl-india-has-banned-342-other-drugs-too/story-4mvpDezyQoqfC7Z12lF9JJ.html

One of India’s most popular medicines for cough and cold, Vicks Action 500 Extra, will not be available in chemist shops any more after the government banned fixed dose combination drugs.
Apart from Vicks, India has banned the manufacture and sale of more than 300 combination medicines, including two widely used cough syrups, being sold without government approval.
The move is aimed at curbing the misuse of such medicines in India, where nearly half the drugs sold in 2014 were so called “fixed dose combinations.”
On Monday, drug majors Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively, after the government banned 344 fixed dose combinations (FDCs) drugs.
The two companies, however, said they are exploring “all options” to counter the impact of ban.
What are combination drugs
Combination drugs are used worldwide to improve patients’ compliance, as it is easier to get patients to take one drug rather than several. But inconsistent enforcement of drug laws in India has led to the proliferation of hundreds of such medicines entering the market based on approval from regulators of individual states, rather than the central government.
In 2014, India set up a committee to review more than 6,000 combinations that had entered the market based only on state regulators’ approval. Policymakers gave pharmaceutical companies a chance to retroactively prove the safety and efficacy of these drugs by submitting data on their drugs.
The committee was tasked with classifying the drugs into rational, irrational, and those that need further studies, said KL Sharma, a joint secretary at the health ministry.
“Now based on responses (and) assessment of products, more than 300 drugs have been prohibited,” he told Reuters.
He did not name the medicines, but said an official notice announcing the ban would be issued “in a few days.” The Drug Controller General of India was not immediately available to comment.

The banned drugs
The banned medicines include the codeine-based cough syrups Phensedyl and Corex.
Phensedyl, made by U.S. drugmaker Abbott Laboratories, accounts for about a third of the Indian cough syrup market, and its sales are estimated to make up more than 3 percent of Abbott’s $1 billion India revenue. Corex is sold by Pfizer Inc.
Reuters reported last October that Indian regulators were privately pressuring drug firms to better police the selling of popular codeine-based cough syrups to tackle smuggling and addiction.
Doctors and public health experts in India and abroad have warned that increasing use of antibiotic combinations in India may be contributing to antibiotic resistance. India is a particular concern as the market share of combination drugs versus single drugs is bigger than anywhere in the world.
Reuters reported in December how a powerful antibiotic cocktail being marketed in India by a unit of Abbott and many other local companies did not carry approval from the central government.
The combination was not approved for sale in major markets such as the United States, United Kingdom, Germany, France, Japan and Australia.
Several medical experts said it did not make sense to prescribe the cocktail for cold symptoms. However, Abbott’s former and current medical representatives said the combination was being promoted and administered as a treatment for a wide variety of illnesses, including colds and fevers.

Comments

Popular posts from this blog

Pancreatic Rest - The cure to Diabetes type 2

Shocked? Well apparently the cure to Diabetes Mellitus or Type 2 Diabetes has been in front of our eyes all along. Type 2 diabetes, is a condition where the body fails to regulate the sugar levels in the blood causes too much or too little insulin to be produced by the pancreas. It usually turns into a life long disease requiring diet control and insulin therapy. According to new research, conducted at McMaster university in Canada, there may be hope for type 2 suffers through an intensive program that involves closely monitoring of diet+exercises+insulin+oral medicines. It basically involves giving rest to your pancreas after which your pancreases returns to normal (according to 40% of the results of study) and you are cured of diabetes or your diabetes is reversed, atleast temporarily. Here are some of the numbers as shared by McMaster University Research Program: 41% of the participants saw their diabetes reverse in just four months after the intensive program. The trial

Why the new Mental Health bill is being hailed by everyone in India right now

Mental health in India has always been greatly stigmatized. We are extremely judgmental of people who say they are depressed and approach a psychiatrist for the same. We talk behind their back and generally brand them as 'mental case'. It wasn't until recently Deepika Padukone followed by a number of other celebs disclosed being depressed and having various mental ailments that to some level it seems that we have reached a stage where we can atleast have a conversation about it.  Recently the mental health care bill of 2013 was passed, that updated a lot of definitions of what constitutes mental health. It has been hailed by the general public as a step in the right direction. Here are some of the salient features of the bill that have really been appreciated by everyone.    1. First and most importantly, the mental health bill decriminalizes suicide. Viewed as a revolutionary move, the bill acknowledges the various mental factors contributing to a person w

Now, BARC Scientists develop Cancer drugs

In a latest in the fight against cancer, scientists from BARC have developed drugs to combat Cancer.                                                                BARC in Mumbai                                              Source - Homi Bhabha National Institute website They have done so with the help of the fruit  Rampatri plant or Gymnema Sylvestre as it is scientifically called. This fruit extract is used to create two anti cancer medicines which can help destroy tumors and help revive cells damaged in radiation. The scientist at Bhabha Atomic Research Center (BARC) based in Anushaktinagar, Mumbai did clinical trials on mices and found that they can help in healing lung cancer and Neuroblastoma, which is a very rare cancer found in children. The Rampatri plant (Image Source - Sakshipost) The BARC scientists hope to start human trials soon and also apply for patents. Hope this fruit extract indeed helps curb cancer and will be available in the Indian market soon.